<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02410460</url>
  </required_header>
  <id_info>
    <org_study_id>MercyFPSC</org_study_id>
    <nct_id>NCT02410460</nct_id>
  </id_info>
  <brief_title>Anesthetics in Rhytidoplasty - A Comparison Study</brief_title>
  <official_title>The Use of Propofol/Ketamine Anesthesia With Bispectral Monitoring (PKA-BIS) Versus Inhalational Anesthetics in Rhytidoplasty - A Prospective, Double-blinded, Randomized Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mercy Facial Plastic Surgery Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mercy Facial Plastic Surgery Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, double-blind, randomized comparison study of different
      anesthesia methods in rhytidoplasty surgery. The study is designed to determine whether
      post-operative side-effect profiles in patients undergoing elective cosmetic facelift surgery
      can be decreased through the use of propofol/ketamine anesthesia with bispectral monitoring
      (PKA-BIS) rather than general anesthesia, without increasing intra-operative time,
      side-effect profiles, or patient recall. Approximately 30 subjects undergoing facelift
      surgery performed by the principal investigator will participate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PKA-BIS arm receives the following medications:

      clonidine 0.1-0.2mg glycopyrrolate 0.2mg propofol infusion titrated to BIS of 60-75 ketamine
      50mg + additional ketamine not to exceed 200mg aggregate dosage throughout the case local
      anesthetic (lidocaine/marcaine mix)

      General Anesthesia arm receives the following medications:

      Pre-operatively:

      Pepcid 20mg Scopolamine 1.5mg transdermal patch Versed 2mg Zofran 8mg Reglan 10mg
      Glycopyrrolate - dose determined by anesthesiologist

      During the case, medication choices and dosing were dependent on the anesthesiologist - all
      general anesthesia cases received inhalational anesthetic (type of anesthetic also varied
      based on anesthesiologist's choice)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (QOR-40/VAS)</measure>
    <time_frame>1 week</time_frame>
    <description>Quality of recovery score (QOR-40) in PACU and POD#1, VAS POD#1 and POD#7</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nausea/vomiting (QOR-40)</measure>
    <time_frame>24 hours</time_frame>
    <description>Quality of recovery score (QOR-40) in PACU and POD#1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to awakening</measure>
    <time_frame>4 hours</time_frame>
    <description>staff recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>4 hours</time_frame>
    <description>staff recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall feeling of well-being (QOR-40/VAS)</measure>
    <time_frame>1 week</time_frame>
    <description>Quality of recovery score (QOR-40) in PACU and POD#1, VAS POD#1 and POD#7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost (reported as a mean)</measure>
    <time_frame>1 day</time_frame>
    <description>comparison between two groups (reported as a mean)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Rhytidoplasty</condition>
  <arm_group>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Received the following medications:
clonidine 0.1-0.2mg glycopyrrolate 0.2mg propofol infusion titrated to BIS of 60-75 ketamine 50mg + additional ketamine not to exceed 200mg aggregate dosage throughout the case local anesthetic (lidocaine/marcaine mix)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Received the following:
Pre-operatively:
famotidine 20mg scopolamine 1.5mg transdermal patch midazolam 2mg ondansetron 8mg metoclopramide 10mg glycopyrrolate - dose determined by anesthesiologist
During the case, medication choices and dosing were dependent on the anesthesiologist - all general anesthesia cases received inhalational anesthetic (type of anesthetic - desfluorane vs. sevofluorane - also varied based on anesthesiologist's choice)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clonidine</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glycopyrrolate</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>marcaine</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>scopolamine</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ondansetron</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metoclopramide</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glycopyrrolate</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine</intervention_name>
    <arm_group_label>PKA-BIS (intravenous anesthesia)</arm_group_label>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>famotidine</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>desflurane</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <arm_group_label>Inhalational anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Female

          -  18 years of age or older

          -  Undergoing elective rhytidoplasty

        Exclusion criteria:

          -  Male

          -  Under 18 years old

          -  Pregnant or breastfeeding

          -  Medically unfit to undergo surgery

          -  Undergoing brow-lift in conjunction with rhytidoplasty (due to the inability to
             properly secure the BIS monitor as it would lie within the surgical field)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mercy Facial Plastic Surgery Center</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2015</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mercy Facial Plastic Surgery Center</investigator_affiliation>
    <investigator_full_name>Kristin A. Jones</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Metoclopramide</mesh_term>
    <mesh_term>Scopolamine Hydrobromide</mesh_term>
    <mesh_term>Butylscopolammonium Bromide</mesh_term>
    <mesh_term>Glycopyrrolate</mesh_term>
    <mesh_term>Famotidine</mesh_term>
    <mesh_term>Anesthetics, Inhalation</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 14, 2016</submitted>
    <returned>April 11, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

